|
|
Article: Topical calcineurin inhibitors can still be used in children.(Skin Disorders)
- Article from:
- Family Practice News
- Article date:
- October 15, 2005
- Author:
CopyrightCOPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BLAINE, WASH. -- Topical calcineurin inhibitors remain an excellent second-line treatment for atopic dermatitis in children, despite a public health advisory by the Food and Drug Administration earlier this year and the promise of a black-box warning in the near future, Robert Sidbury, M.D., said at a conference sponsored by the North Pacific Pediatric Society.
Dr. Sidbury; of the University of Washington, Seattle, addressed the questions of when and how to use the topical calcineurin inhibitor (TCI) tacrolimus (Protopic) and pimecrolimus (Elidel) for atopic dermatitis in light of the FDA warning.
TCIs should be used only for short-term or intermittent ...